DUBLIN, May 29, 2024 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
fireside chat presentations at two upcoming investor
conferences.
Jefferies Healthcare Conference
Date/Time:
Thursday, June 6, 2024 at
1:30 p.m. EDT (6:30 p.m. BST)
Goldman Sachs 45th Annual Global Healthcare
Conference
Date/Time: Tuesday,
June 11, 2024 at 10:40 a.m.
EDT (3:40 p.m. BST)
The live webcasts may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and bipolar I
disorder, and a pipeline of clinical and preclinical candidates in
development for neurological disorders, including narcolepsy.
Headquartered in Ireland, Alkermes
also has a corporate office and research and development center in
Massachusetts and a manufacturing
facility in Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-302158285.html